DE602004030334D1 - Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen - Google Patents

Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen

Info

Publication number
DE602004030334D1
DE602004030334D1 DE602004030334T DE602004030334T DE602004030334D1 DE 602004030334 D1 DE602004030334 D1 DE 602004030334D1 DE 602004030334 T DE602004030334 T DE 602004030334T DE 602004030334 T DE602004030334 T DE 602004030334T DE 602004030334 D1 DE602004030334 D1 DE 602004030334D1
Authority
DE
Germany
Prior art keywords
substituted
azaindolines
azaindoles
synthesis
azaindoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004030334T
Other languages
English (en)
Inventor
P Graczyk
A Khan
G Bhatia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Publication of DE602004030334D1 publication Critical patent/DE602004030334D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004030334T 2003-03-06 2004-03-05 Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen Expired - Lifetime DE602004030334D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0305142.2A GB0305142D0 (en) 2003-03-06 2003-03-06 Synthesis
PCT/GB2004/000946 WO2004078757A2 (en) 2003-03-06 2004-03-05 Synthesis of 5-substituted 7-azaindoles and 7-azaidonines

Publications (1)

Publication Number Publication Date
DE602004030334D1 true DE602004030334D1 (de) 2011-01-13

Family

ID=9954241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030334T Expired - Lifetime DE602004030334D1 (de) 2003-03-06 2004-03-05 Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen

Country Status (8)

Country Link
US (1) US7652137B2 (de)
EP (1) EP1633750B1 (de)
JP (1) JP4711950B2 (de)
AT (1) ATE490253T1 (de)
DE (1) DE602004030334D1 (de)
ES (1) ES2355726T3 (de)
GB (1) GB0305142D0 (de)
WO (1) WO2004078757A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003202094B2 (en) * 2002-02-01 2009-10-08 Astrazeneca Ab Quinazoline compounds
KR20040111445A (ko) * 2002-03-28 2004-12-31 에자이 가부시키가이샤 신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
US7612086B2 (en) * 2003-05-16 2009-11-03 Eisai R & D Management Co. Ltd. JNK inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US7626021B2 (en) 2004-07-27 2009-12-01 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
MX2007001127A (es) 2004-07-27 2007-07-11 Sgx Pharmaceuticals Inc Moduladores de pirrolo-piridina cinasa.
MX2007001126A (es) 2004-07-27 2007-09-25 Sgx Pharmaceuticals Inc Moduladores de heterociclo cinasa de anillo fusionado.
US7361764B2 (en) 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
EP2029593A1 (de) * 2006-05-22 2009-03-04 AstraZeneca AB Indolderivate
JP6073677B2 (ja) 2009-06-12 2017-02-01 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 縮合複素環式化合物およびそれらの使用
WO2011060216A1 (en) 2009-11-12 2011-05-19 Concert Pharmaceuticals Inc. Substituted azaindoles
CA2784807C (en) * 2009-12-29 2021-12-14 Dana-Farber Cancer Institute, Inc. Type ii raf kinase inhibitors
WO2011109932A1 (en) * 2010-03-09 2011-09-15 F.Hoffmann-La Roche Ag Novel process for the manufacture of 5-halogenated-7-azaindoles
JP2013531636A (ja) * 2010-05-26 2013-08-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ２−オキソ−１，２−ジヒドロピリジン−４−イルボロン酸誘導体
US9382239B2 (en) 2011-11-17 2016-07-05 Dana-Farber Cancer Institute, Inc. Inhibitors of c-Jun-N-terminal kinase (JNK)
EP2909194A1 (de) 2012-10-18 2015-08-26 Dana-Farber Cancer Institute, Inc. Hemmer der cyclinabhängigen kinase 7 (cdk7)
WO2014063054A1 (en) 2012-10-19 2014-04-24 Dana-Farber Cancer Institute, Inc. Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
USRE48175E1 (en) 2012-10-19 2020-08-25 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged small molecules as inducers of protein degradation
AP2015008721A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US20160264551A1 (en) 2013-10-18 2016-09-15 Syros Pharmaceuticals, Inc. Heteroaromatic compounds useful for the treatment of prolferative diseases
EP3057956B1 (de) 2013-10-18 2021-05-05 Dana-Farber Cancer Institute, Inc. Polycyclische inhibitoren der cyclin-dependent-kinase 7 (cdk7)
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
US10246455B2 (en) 2014-04-11 2019-04-02 Taipei Medical University Histone deacetylase inhibitors
WO2015164604A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Hydrophobically tagged janus kinase inhibitors and uses thereof
WO2015164614A1 (en) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Janus kinase inhibitors and uses thereof
CN104478909B (zh) * 2014-11-19 2017-01-04 上海泰坦科技股份有限公司 杂环硼酸类化合物的合成工艺
WO2016105528A2 (en) 2014-12-23 2016-06-30 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
US10550121B2 (en) 2015-03-27 2020-02-04 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
AU2016276963C1 (en) 2015-06-12 2021-08-05 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
EP4019515A1 (de) 2015-09-09 2022-06-29 Dana-Farber Cancer Institute, Inc. Hemmer von cyclinabhängigen kinasen
EP3351533A4 (de) 2015-09-18 2019-03-06 Kaken Pharmaceutical Co., Ltd. Biarylderivat sowie medikament damit
CN105622605B (zh) * 2016-03-01 2017-10-13 苏州艾缇克药物化学有限公司 一种5‑溴‑7‑氮杂吲哚的合成方法
CN106188050A (zh) * 2016-07-20 2016-12-07 南通雅本化学有限公司 一种5‑溴‑7‑氮杂吲哚的生产工艺
CN107033142A (zh) * 2017-05-15 2017-08-11 杭州科耀医药科技有限公司 一种Venetoclax关键中间体的合成方法
CN110078726B (zh) * 2019-06-19 2022-05-17 陕西师范大学 一种全取代2,3-二氢-1H-吡咯并[2,3-b]吡啶衍生物的合成方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
JPH0830013B2 (ja) * 1989-07-28 1996-03-27 財団法人相模中央化学研究所 ビアリール化合物の製造方法
GB9026926D0 (en) 1990-12-12 1991-01-30 Smith Kline French Lab Novel process
EP0563286A4 (en) 1990-12-13 1995-01-11 Smithkline Beecham Corp Novel csaids
SE9100920D0 (sv) 1991-03-27 1991-03-27 Astra Ab New active compounds
JP3119758B2 (ja) 1993-02-24 2000-12-25 日清製粉株式会社 ７−アザインドール誘導体及びこれを有効成分とする抗潰瘍薬
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
FR2732969B1 (fr) 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU7132998A (en) 1997-04-24 1998-11-13 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
GB9721437D0 (en) 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
CN1279682A (zh) 1997-10-20 2001-01-10 霍夫曼-拉罗奇有限公司 双环激酶抑制剂
JP2002510630A (ja) 1998-04-02 2002-04-09 メルク エンド カムパニー インコーポレーテッド 性腺刺激ホルモン放出ホルモン拮抗薬
JP2002528542A (ja) * 1998-10-30 2002-09-03 メルク エンド カムパニー インコーポレーテッド トロンビン阻害剤
AU747776B2 (en) 1998-10-30 2002-05-23 Merck & Co., Inc. Thrombin inhibitors
KR20010101266A (ko) 1998-12-17 2001-11-14 프리돌린 클라우스너, 롤란드 비. 보레르 Ｊｎｋ 단백질 키나제의 억제제로서의 4-아릴옥신돌
CN1158283C (zh) 1998-12-17 2004-07-21 霍夫曼-拉罗奇有限公司 作为蛋白激酶抑制剂的4-和5-吡嗪基羟吲哚
US6265403B1 (en) 1999-01-20 2001-07-24 Merck & Co., Inc. Angiogenesis inhibitors
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
ATE425142T1 (de) 1999-04-23 2009-03-15 Vertex Pharma Inhibitoren von c-jun n-terminal kinasen (jnk)
US6239132B1 (en) 1999-04-23 2001-05-29 Merck & Co., Inc. Thrombin inhibitors
EP1218347A1 (de) 1999-08-19 2002-07-03 Signal Pharmaceuticals, Inc. Pyrazoloanthrone und deren derivate als jnk inhibitoren und ihre zusammensetzungen
DE60006634T2 (de) 1999-12-07 2004-04-15 Fuji Photo Film Co., Ltd., Minami-Ashigara Fluoreszente materialen
EP1263759B1 (de) 1999-12-24 2010-09-08 Aventis Pharma Limited Azaindole
CA2396257A1 (en) 2000-01-06 2001-07-12 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Novel compounds and compositions as protease inhibitors
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
PE20020506A1 (es) 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
WO2002024648A2 (en) * 2000-09-20 2002-03-28 Abbott Laboratories Process for the preparation of cell proliferation inhibitors
GB0108770D0 (en) * 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
WO2003028724A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
CN100338062C (zh) * 2002-03-28 2007-09-19 卫材株式会社 作为c－Jun N－末端激酶抑制剂的氮杂吲哚类化合物
KR20040111445A (ko) 2002-03-28 2004-12-31 에자이 가부시키가이샤 신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
EP2295433A3 (de) * 2003-03-06 2011-07-06 Eisai R&D Management Co., Ltd. JNK Inhibitoren
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors

Also Published As

Publication number Publication date
ATE490253T1 (de) 2010-12-15
JP4711950B2 (ja) 2011-06-29
EP1633750A2 (de) 2006-03-15
GB0305142D0 (en) 2003-04-09
US7652137B2 (en) 2010-01-26
ES2355726T3 (es) 2011-03-30
EP1633750B1 (de) 2010-12-01
WO2004078757A3 (en) 2005-09-01
US20060235042A1 (en) 2006-10-19
JP2006520771A (ja) 2006-09-14
WO2004078757A2 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
ATE360627T1 (de) Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
ATE357434T1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
IL178156A0 (en) Intermediates for the preparation of pramipexole
SE0202133D0 (sv) Novel compounds
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ECSP045255A (es) Cumarinas utiles como biomarcadores
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
TW200626564A (en) Carboxylic acid derivative containing thiazole ring and medical use thereof
SE0403171D0 (sv) New compounds
MXPA05011962A (es) Oxiarenos substituidos.
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
SE0303541D0 (sv) New compounds
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE411287T1 (de) Neue metallproteinaseinhibitoren
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
NO20053562L (no) Nye aminobenzofenonforbindelser
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
ATE390427T1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande